You are here » Home » Companies ยป Company Overview » Metropolis Healthcare Ltd

Metropolis Healthcare Ltd.

BSE: 542650 Sector: Health care
NSE: METROPOLIS ISIN Code: INE112L01020
BSE 00:00 | 03 Feb 1224.10 -90.60
(-6.89%)
OPEN

1301.20

HIGH

1316.70

LOW

1220.10

NSE 00:00 | 03 Feb 1224.15 -91.65
(-6.97%)
OPEN

1308.10

HIGH

1320.35

LOW

1220.00

OPEN 1301.20
PREVIOUS CLOSE 1314.70
VOLUME 8878
52-Week high 2670.00
52-Week low 1220.10
P/E 45.95
Mkt Cap.(Rs cr) 6,267
Buy Price 0.00
Buy Qty 0.00
Sell Price 0.00
Sell Qty 0.00
OPEN 1301.20
CLOSE 1314.70
VOLUME 8878
52-Week high 2670.00
52-Week low 1220.10
P/E 45.95
Mkt Cap.(Rs cr) 6,267
Buy Price 0.00
Buy Qty 0.00
Sell Price 0.00
Sell Qty 0.00

Metropolis Healthcare Ltd. (METROPOLIS) - Chairman Speech

Company chairman speech

MESSAGE FROM CHAIRMAN'S DESK

We are becoming a self-reliant world-class pathology services provider driven by robustR&D technological capabilities and industry experience.

Dear Stakeholders

The world has been volatile in 2021-22. Looking back at the past two years we all havewitnessed tumultuous times due to the Covid-19 pandemic. After the three waves of thepandemic the Indian economy is finally reviving with a positive trend in all macroindicators. This shows that the country is on the path of growth. Further large-scalevaccination drives and rising economic activity have collectively boosted public morale.The Indian Government has also contributed to the country's growth story through variouspolicies and budgetary allocations.

The diagnostic companies have rapidly expanded to respond and maintain pace with theincreasing demand for testing volumes. Additionally an increased emphasis seriousnessand awareness of personal health are equally responsible for providing diagnosticsindustry with an opportunity to expand and facilitate the best solutions in thenon-Covid-19 testing segments.

When it comes to Covid-19 and identifying the variants of concern the technology usedfor sequencing matters the most. Several labs across the country have upgraded to cater tothis growing need and serve the nation at this crucial time. Another big shift has beenthe fact that these services have been brought to homes thereby reducing infectionchances further. The turnaround time has also been brought down to bare minimum andspecial testing packages have also helped ensure familial health without burning a hole inpeople's pockets. On the other hand non-Covid-19 testing volumes have seen a surge whereregular check-ups have gained popularity – assuring to help the nation oneindividual at a time.

The Indian diagnostic industry has been rapidly evolving over the years and has emergedto be the key component of the healthcare segment. As a scientific-driven healthcareorganization Metropolis has always been at the forefront in clinical validation oftechnologies tests and platforms that directly ensure an accurate timely diagnosis to thepatient including Digital Pathology (whole Slide Imaging) FDA approved Immunotherapytargeted therapy biomarkers liquid biopsy medical genetics by array cGH analyticalchemistry pharmacogenomics COvID diagnostic & prognostic assays etc. We aim tonurture and expand the scope for Oncology Pre-natal testing Transplant ImmunologyInfectious and Chronic diseases through next-generation sequencing and artificialintelligence. this goal and to catalyze optimal patient management we have established‘Metropolis Innovation Cell' to focus on Molecular Genomics Super SpecialtyPathology and Companion Diagnostics. We will continue to build our capabilities indifferent areas and will look out for more opportunities to offer ‘affordable'testing to patients as we penetrate further into tier 2 and tier 3 cities. Identificationof the root cause of any disease is a battle half won. That is where the diagnosticssector comes in. We not only identify the root cause but also study patterns and cansuggest preventive measures to curb the situation. The information hence gathered can berelayed to respective sectors of clinicians pharma and disease experts among others tonip the problem right in the bud.

The study of long-term data equally helps the Government to mandate well-informedcity-specific or nationwide decisions and protocols.

Metropolis is a science-based diagnostic lab chain and has always been a pioneer inintroducing specialized tests. We started our journey as a specialized test lab and haveslowly and steadily earned the trust of doctors over the last 40+ years. Our primarymotive is to provide accurate test results that help our customers make better healthdecisions. We are becoming a reliant world-class pathology services provider driven byrobust R&D technological capabilities and industry experience.

The ongoing coronavirus pandemic has changed people's perspectives on many things. Dueto lockdowns curfews and Covid-19 restrictions people have realized that there are alot of things that can be done in the comforts of their homes. Gone are the days whenpeople used to stand in queues for a visit to the doctors or to submit their samples inthe lab. Our digital and other initiatives are aligned with this trend and are furtherstreamlining processes to help our patients and customers serve better.

PEOPLE AND CULTURE

At Metropolis we remain compassionate to all our stakeholders. We have alwaysprioritized people and will continue holding on to this value that helps us navigate andovercome challenges. We ensure that all our employees are encouraged to view safety as ashared responsibility. We recognize the importance of our employees in shaping asustainable future and strive to foster a corporate culture that aligns business goalswith the growth and development of our people.

"the Company its promoters and the management team are committed to operatingMetropolis Healthcare Limited with the highest standards of medical science stakeholdertrust and customer engagement."

OUR COMMITMENT TO QUALITY SERVICE

Torealize Over the years we have worked efficiently and provided best-in-classpathology services to our customers. Our optimistic mindset is what drives us towardscontinuous improvement for our Company and new diagnostic test solutions for ourcustomers. We strive to provide better service by adapting newer technology. We havebrought our new patient app with a revamped user-friendly interface.

This app will help our customers constantly monitor their test results' status andnavigate many more features. This action will further lead us to achieve our next leg ofgrowth.

SUSTAINABILITY

We recognize that acting responsibly and sustainably is part of being a responsiblesteward of our planet. We have taken numerous steps over the years to reduce ourenvironmental impact both in our operations and in the services which we deliver to ourcustomers. We have been attempting this through energy efficiency and biomedical wastemanagement. We acknowledge that our operations have an indirect environmental impact andare working towards reducing the same. I would like to take this opportunity to let youknow that we are now embarking on our ESG (Environment Social and Governance) journeywith a vision to create a wider impact for the greater good.

GOVERNANCE FOR DELIVERING VALUE

Our corporate governance structure promotes accountability and transparency with astrong and diverse Board of Directors best practices internal and external – andleading diversity disclosure practices. All of this is not only the right thing to do butit is also good business. Our culture and industry-leading social and environmentalpractices enable us to attract top talent and strengthen our industry leadership whilemaking the world a better place.

GRATITUDE

we are committed to the Metropolis philosophy of customer centricity in all that we do.We are completely dedicated to serving our customers. I am extremely grateful to theemployees doctors leadership team Board members and all stakeholders who havesupported us during our challenging times. As an exciting future awaits I look forward toplaying a role in the Company's next growth phase and assisting the team in building along-term sustainable business.

warm regards
dr. Sushil Shah
Founder & chairman

.